Company intelligence / Profile preview
Yikang Biotech
Suzhou, Jiangsu, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Yikang Biotech (Suzhou) Co., Ltd. is a Chinese biotechnology company founded in 2017, specializing in the structure-based design and development of next-generation vaccines and antibody therapeutics. Leveraging its advanced structural biology platform, which utilizes protein crystallography and cryo-electron microscopy, the company designs highly precise antigens to target viral pathogens. Yikang Biotech's lead program is a recombinant respiratory syncytial virus (RSV) vaccine (CHO cell-expressed, targeting the prefusion F glycoprotein) which entered Phase 1 clinical trials in China in August 2024. The company also develops veterinary vaccines, including a porcine epidemic diarrhea genetic engineering subunit vaccine in collaboration with Jinyu Baoling.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineRecombinant proteinBiologicmRNA-based drugsAntibody
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Jiangsu Recbio Technology Co., Ltd.Jinyu Baoling Bio-pharmaceutical Co., Ltd.
Beyond the preview
Go deeper on Yikang Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yikang Biotech.